Current status: 827 hESC lines, 3058 hiPSC lines, and 95 clinical studies, and 388 certificates
Monthly statistic from Mar 1, 2022
Posted on March 1, 2022
| total lines | 3885 |
| hESC lines | 827 |
| hiPSC lines | 3058 |
| derivation countries | 40 |
| projects | 219 |
| providers | 699 |
| clinical studies | 95 |
| subclones | 1478 |
| certificates | 388 |
| cell line certificates | 279 |
| project certificates | 109 |